InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Follow-Up Questions
What is Inmode Ltd (INMD)'s P/E Ratio?
The P/E ratio of Inmode Ltd is 5.7673
Who is the CEO of Inmode Ltd?
Mr. Moshe Mizrahy is the Chief Executive Officer of Inmode Ltd, joining the firm since 2008.
What is the price performance of INMD stock?
The current price of INMD is $15.02, it has decreased 0.98% in the last trading day.
What are the primary business themes or industries for Inmode Ltd?
Inmode Ltd belongs to Health Care industry and the sector is Health Care
What is Inmode Ltd market cap?
Inmode Ltd's current market cap is $949.4M
Is Inmode Ltd a buy, sell, or hold?
According to wall street analysts, 7 analysts have made analyst ratings for Inmode Ltd, including 2 strong buy, 4 buy, 7 hold, 0 sell, and 2 strong sell
